Why You'll Love Moderna's Latest COVID Vaccine News
Perhaps the best news of all related to coronavirus vaccines is just how much good news there's been. The development of experimental vaccines proceeded breathtakingly fast in 2020. Two vaccines with high efficacy levels won U.S. Food and Drug Administration (FDA) emergency use authorization. Millions of Americans have already been vaccinated, with many more on the way.
Now there's more good news. Here's why you'll love Moderna's (NASDAQ: MRNA) latest COVID vaccine update.
Image source: Getty Images.
Source Fool.com
